Onc Now
In this episode of Onc Now, Stephen Chan, Clinical Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong, explores the evolving landscape of hepatobiliary and pancreatic cancers. From advances in translational science and precision therapies to the challenges of neuroendocrine tumour care, Chan reflects on the progress made in oncology and the breakthroughs still needed. He also discusses his work with the Hand-in-Hand Cancer Foundation, highlighting the importance of education, compassion, and holistic support for patients and their families.
Speaker bio:
Stephen Chan is Clinical Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong. Over the past two decades, he has dedicated his work to advancing the clinical management of hepatobiliary, pancreatic, and neuroendocrine tumours through clinical trials and translational research. His research focuses on hepato-pancreatobiliary cancers and neuroendocrine tumours, spanning both clinical and translational oncology.
Timestamps:
00:00 – Introduction
01:18 – Current Hepatobiliary and Pancreatic Landscape
03:23 – Translational Science and Patient Outcomes
05:06 – Founding the Hand-in-Hand Cancer Foundation
06:53 – Advances in Precision Cancer Therapies
08:54 – Rising Incidence of Pancreatic Cancer Post COVID-19
10:45 – President of the International Liver Cancer Association
12:46 – Challenges in Neuroendocrine Tumour Care
14:32 – Future Breakthroughs in Cancer Care
16:02 – Three Wishes for Oncology’s Future
Disclaimer: The opinions expressed in this episode belong to the speakers and do not necessarily represent the opinions of EMJ.
